Submitted by Anonymous (not verified) on 8 August 2023 - 12:54
Human medicines European public assessment report (EPAR): Vpriv, velaglucerase alfa, Gaucher Disease, Date of authorisation: 26/08/2010, Revision: 20, Status: Authorised
Source: